MARSHALL WACE, LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$379,474
-81.3%
6,333
-77.0%
0.00%
-75.0%
Q1 2023$2,029,005
-67.3%
27,583
-70.3%
0.00%
-71.4%
Q4 2022$6,203,249
+80.6%
92,863
+132.8%
0.01%
+75.0%
Q3 2022$3,434,000
-3.5%
39,8830.0%0.01%
+14.3%
Q2 2022$3,559,000
+191.0%
39,883
+354.5%
0.01%
+40.0%
Q3 2021$1,223,000
+91.7%
8,776
+36.8%
0.01%
+66.7%
Q4 2020$638,000
+72.9%
6,415
+26.3%
0.00%
-25.0%
Q1 2020$369,000
-89.3%
5,078
-83.2%
0.00%
-85.7%
Q2 2019$3,448,000
-75.6%
30,205
-73.1%
0.03%
-58.2%
Q1 2019$14,122,000
-32.7%
112,322
-27.3%
0.07%
-68.7%
Q4 2018$20,971,000
+3383.6%
154,535
+6956.4%
0.21%
+7033.3%
Q3 2018$602,000
-48.7%
2,190
-61.3%
0.00%
-83.3%
Q2 2018$1,173,000
-76.8%
5,662
-94.0%
0.02%
-73.1%
Q4 2014$5,062,000
-44.5%
95,128
-51.0%
0.07%
-49.2%
Q3 2014$9,125,000
+4224.6%
194,181
+5631.4%
0.13%
+4300.0%
Q2 2014$211,000
-93.4%
3,388
-92.8%
0.00%
-94.8%
Q1 2014$3,179,00047,2710.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders